Brokers usually take bids until: Zerodha 4:45 PM, Groww 4:50 PM, Angel One and Upstox 5:00 PM (HNI 4:00 PM). Check the exact time with your broker or bank.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
Diagnostic centre network expansion
Funding the cost of establishing new diagnostic centres in Punjab, Karnataka, Himachal Pradesh and Maharashtra.
Debt repayment
Full or partial repayment or prepayment of certain outstanding borrowings of the company.
General corporate purposes
General corporate purposes.
No documents added yet.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
No peer comparisons added yet.
Krsnaa Diagnostics Limited operates a diagnostics services business spanning radiology and imaging (X-ray, CT, MRI and related modalities), clinical pathology and laboratory testing, and tele-radiology reporting. The company serves a mix of public-sector hospitals, medical colleges and community health centres as well as private healthcare providers, largely through long-term public-private-partnership (PPP) contracts under which it sets up and runs diagnostic centres on behalf of state governments and public health bodies. Built out over more than a decade, the company had grown to operate a network of diagnostic centres across roughly a dozen Indian states by the time of its public issue, making it one of the more prominent PPP-model diagnostic chains in the country. Its network combines centre-based imaging and lab facilities with a centralised tele-radiology hub that lets radiologists report scans remotely, extending specialist coverage to smaller towns and semi-urban areas that would otherwise lack access to advanced diagnostics. The company's growth approach has centred on winning and renewing government PPP tenders, expanding its centre count in both existing and new states, and using its tele-radiology infrastructure to scale specialist reporting capacity without a proportional rise in on-ground radiologist headcount. This contract-anchored model differentiates it from purely private, cash-pay diagnostic chains and was a key driver of its revenue growth in the years leading up to listing.
No anchor investors added yet.
Source: RHP • Analysis provided for informational purposes
Last Updated: 21 July 2026, 5:30 AM
Leading PPP-model diagnostics network
One of the largest differentiated diagnostic chains in India, built around public-private-partnership contracts that give it a broad, largely institutional revenue base and an active centre-expansion pipeline.
FY21 profit driven by one-off gains
The company swung to profit in FY21 after two years of losses, but a meaningful part of the improvement came from one-time or exceptional items rather than recurring operations, so the FY21 run-rate may not repeat.
Aggressive issue pricing
The issue was priced at a price-to-earnings multiple in excess of 80x on reported earnings, a demanding valuation relative to listed diagnostics peers that leaves little room for execution slippage.
Krsnaa Diagnostics Limited
Company contact details are not available.
KFin Technologies Limited
No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.